Austin et al. (2014) showed that, in CML cells, SLC22A1 expression can be induced by both permissive heterodimer PXR/RXR and PPAR/RXR and non-permissive heterodimer RAR/RXR [216]. The gene discussed is SLC22A1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.